146 related articles for article (PubMed ID: 27249600)
1. MiR-183 modulates multi-drug resistance in hepatocellular cancer (HCC) cells via miR-183-IDH2/SOCS6-HIF-1α feedback loop.
Wang XJ; Zhang DL; Fu C; Wei BZ; Li GJ
Eur Rev Med Pharmacol Sci; 2016 May; 20(10):2020-7. PubMed ID: 27249600
[TBL] [Abstract][Full Text] [Related]
2. The HIF-2α-MALAT1-miR-216b axis regulates multi-drug resistance of hepatocellular carcinoma cells via modulating autophagy.
Yuan P; Cao W; Zang Q; Li G; Guo X; Fan J
Biochem Biophys Res Commun; 2016 Sep; 478(3):1067-73. PubMed ID: 27524242
[TBL] [Abstract][Full Text] [Related]
3. MiR-27a modulates the MDR1/P-glycoprotein expression by inhibiting FZD7/β-catenin pathway in hepatocellular carcinoma cells.
Chen Z; Ma T; Huang C; Zhang L; Lv X; Xu T; Hu T; Li J
Cell Signal; 2013 Dec; 25(12):2693-701. PubMed ID: 24018051
[TBL] [Abstract][Full Text] [Related]
4. Characterization and resistance mechanisms of a 5-fluorouracil- resistant hepatocellular carcinoma cell line.
Gu W; Fang FF; Li B; Cheng BB; Ling CQ
Asian Pac J Cancer Prev; 2012; 13(9):4807-14. PubMed ID: 23167424
[TBL] [Abstract][Full Text] [Related]
5. miRNA-195 sensitizes human hepatocellular carcinoma cells to 5-FU by targeting BCL-w.
Yang X; Yin J; Yu J; Xiang Q; Liu Y; Tang S; Liao D; Zhu B; Zu X; Tang H; Lei X
Oncol Rep; 2012 Jan; 27(1):250-7. PubMed ID: 21947305
[TBL] [Abstract][Full Text] [Related]
6. MiR-223 modulates multidrug resistance via downregulation of ABCB1 in hepatocellular carcinoma cells.
Yang T; Zheng ZM; Li XN; Li ZF; Wang Y; Geng YF; Bai L; Zhang XB
Exp Biol Med (Maywood); 2013 Sep; 238(9):1024-32. PubMed ID: 23925649
[TBL] [Abstract][Full Text] [Related]
7. Reversal effect of bufalin on multidrug resistance in human hepatocellular carcinoma BEL-7402/5-FU cells.
Gu W; Liu L; Fang FF; Huang F; Cheng BB; Li B
Oncol Rep; 2014 Jan; 31(1):216-22. PubMed ID: 24173654
[TBL] [Abstract][Full Text] [Related]
8. [Establishment of a multidrug-resistant cell line BEL-7402/5-FU of human hepatocellular carcinoma and its biological characteristics].
Gu W; Zhang YN; Li B; Han J; Cheng BB; Ling CQ
Zhong Xi Yi Jie He Xue Bao; 2006 May; 4(3):265-70. PubMed ID: 16696913
[TBL] [Abstract][Full Text] [Related]
9. HIF-1α Induces Multidrug Resistance in Gastric Cancer Cells by Inducing MiR-27a.
Zhao Q; Li Y; Tan BB; Fan LQ; Yang PG; Tian Y
PLoS One; 2015; 10(8):e0132746. PubMed ID: 26292288
[TBL] [Abstract][Full Text] [Related]
10. MiR-338-3p inhibits hepatocarcinoma cells and sensitizes these cells to sorafenib by targeting hypoxia-induced factor 1α.
Xu H; Zhao L; Fang Q; Sun J; Zhang S; Zhan C; Liu S; Zhang Y
PLoS One; 2014; 9(12):e115565. PubMed ID: 25531114
[TBL] [Abstract][Full Text] [Related]
11. [Reversion of drug-resistant hepatocellular carcinoma cell line BEL-7402/FU by sorafenib].
Wei L; Su N; Zheng DY; Cao MR; Li AM; Yan X; Lü CW; Luo RC
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Apr; 25(4):344-7. PubMed ID: 19351508
[TBL] [Abstract][Full Text] [Related]
12. MiR-21 and miR-183 can simultaneously target SOCS6 and modulate growth and invasion of hepatocellular carcinoma (HCC) cells.
Li ZB; Li ZZ; Li L; Chu HT; Jia M
Eur Rev Med Pharmacol Sci; 2015 Sep; 19(17):3208-17. PubMed ID: 26400524
[TBL] [Abstract][Full Text] [Related]
13. [Expression of ERK5 in multidrug-resistant hepatocellular carcinoma cell line].
Yan F; Wang XM; Pan C
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Mar; 29(3):483-6. PubMed ID: 19304531
[TBL] [Abstract][Full Text] [Related]
14. Biological features, gene expression profile, and mechanisms of drug resistance of two- and three-dimensional hepatocellular carcinoma cell cultures.
Mei N; Zhao N; Tian T; Jiao M; Li C
Pharmacol Res Perspect; 2021 Feb; 9(1):e00715. PubMed ID: 33486902
[TBL] [Abstract][Full Text] [Related]
15. miR-592/WSB1/HIF-1α axis inhibits glycolytic metabolism to decrease hepatocellular carcinoma growth.
Jia YY; Zhao JY; Li BL; Gao K; Song Y; Liu MY; Yang XJ; Xue Y; Wen AD; Shi L
Oncotarget; 2016 Jun; 7(23):35257-69. PubMed ID: 27153552
[TBL] [Abstract][Full Text] [Related]
16. Quantitative proteomic and phosphoproteomic studies reveal novel 5-fluorouracil resistant targets in hepatocellular carcinoma.
Liu Z; Wang Y; Yao Y; Fang Z; Miao QR; Ye M
J Proteomics; 2019 Sep; 208():103501. PubMed ID: 31454556
[TBL] [Abstract][Full Text] [Related]
17. Reversal effect of melanoma differentiation associated gene-7/interleukin-24 on multidrug resistance in human hepatocellular carcinoma cells.
Fang P; Zhang X; Gao Y; Ding CR; Cui F; Jiao SC
Anat Rec (Hoboken); 2012 Oct; 295(10):1639-46. PubMed ID: 22899557
[TBL] [Abstract][Full Text] [Related]
18. MiR-29a Curbs Hepatocellular Carcinoma Incidence via Targeting of
Huang YH; Lian WS; Wang FS; Wang PW; Lin HY; Tsai MC; Yang YL
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163556
[TBL] [Abstract][Full Text] [Related]
19. lncRNA KRAL reverses 5-fluorouracil resistance in hepatocellular carcinoma cells by acting as a ceRNA against miR-141.
Wu L; Pan C; Wei X; Shi Y; Zheng J; Lin X; Shi L
Cell Commun Signal; 2018 Aug; 16(1):47. PubMed ID: 30119680
[TBL] [Abstract][Full Text] [Related]
20. HIFs-MiR-33a-Twsit1 axis can regulate invasiveness of hepatocellular cancer cells.
Guo XF; Wang AY; Liu J
Eur Rev Med Pharmacol Sci; 2016 Jul; 20(14):3011-6. PubMed ID: 27460728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
